Malmstrom, A. Et Al. 2010. Glioblastoma (GBM) in elderly patients: A randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ). JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.18 .

Malmstrom, A., Gronberg, B. H., Stupp, R., Marosi, C., Frappaz, D., Schultz, H. P., ... Abacioglu, M. U.(2010). Glioblastoma (GBM) in elderly patients: A randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ). JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.18.

Malmstrom, A. Et Al. "Glioblastoma (GBM) in elderly patients: A randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ)," JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.18, 2010

Malmstrom, A. Et Al. "Glioblastoma (GBM) in elderly patients: A randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ)." JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.18, 2010

Malmstrom, A. Et Al. (2010) . "Glioblastoma (GBM) in elderly patients: A randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ)." JOURNAL OF CLINICAL ONCOLOGY , vol.28, no.18.

@article{article, author={A. Malmstrom Et Al. }, title={Glioblastoma (GBM) in elderly patients: A randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ)}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2010}